Quantcast

Latest Finasteride Stories

2009-05-06 06:30:00

SEATTLE, May 6 /PRNewswire-FirstCall/ -- Dendreon Corporation (Nasdaq: DNDN) today reported results for the first quarter ended March 31, 2009. Revenue for the first quarter of 2009 was $30,000 compared to $31,000 for the quarter ended March 31, 2008. Dendreon's total operating expenses for the three months ended March 31, 2009 were $17.0 million compared to $19.2 million for the same period in 2008. The net loss for the quarter ended March 31, 2009 was $15.4 million, or $0.16 per share...

2009-04-28 10:30:00

-- Data Presented at American Urological Association Annual Meeting -- SEATTLE and CHICAGO, April 28 /PRNewswire-FirstCall/ -- Researchers from Dendreon Corporation (Nasdaq: DNDN) today presented preclinical data demonstrating the potential of D-3263, Dendreon's orally bioavailable small molecule, which targets TRPM8 (a transmembrane cation channel protein), to treat benign prostatic hyperplasia (BPH). D-3263 demonstrated the ability to reduce BPH alone and in combination with finasteride,...

2009-04-28 08:09:00

REDUCE Trial data presented during American Urological Association Annual Meeting, April 27 CHICAGO, April 28 /PRNewswire-USNewswire/ -- Dutasteride (Avodart), a commonly prescribed drug to treat benign prostatic hyperplasia, has been shown to lower the risk of prostate cancer by 23 percent in men with an increased risk of the disease, according to results of an international clinical trial presented yesterday at the American Urological Association (AUA) Annual Meeting in Chicago. Data from...

2009-04-28 06:00:00

HOUSTON, April 28 /PRNewswire/ -- SeqWright Inc., a CLIA certified and GLP compliant provider of custom genomic and molecular biology services, announced today its entry into the genetically-targeted therapy field through its partnership with PharmaGenoma. SeqWright will be the exclusive genetic testing provider for PharmaGenoma's HairDX test which evaluates patient responsiveness to the common hair loss treatment, Finasteride. Finasteride is a commonly prescribed medication for the...

2009-04-27 07:00:00

DENVER, April 27 /PRNewswire-USNewswire/ -- Phase II data presented at the annual meeting of the American Urology Association (AUA) indicate that men suffering from an enlarged prostate may benefit from BOTOX(R) injections. The two-stage, multi-center, double-blind, randomized study showed that two different dose levels of Botulinium Neurotoxin Type A (BOTOX) injected into the prostate was both safe and efficacious for the management of benign prostatic hyperplasia (BPH), a common...

44424ee3c233f1d1fbf3f7f996c2d74c1
2009-02-25 06:45:00

Important medical groups are recommending that healthy men use regular tests and should think about taking a drug that may prevent future prostate cancer. They do not outright say that adults should take the drug finasteride, generically called Proscar. Like all prescription drugs, there are both benefits and risks and it can be confusing. The drug reduces the chance contracting prostate cancer by 25 percent. "If a man is interested enough in being screened, then at least he ought to have...

2008-10-28 12:00:39

Pharmacogenomics research and development innovator PharmaGenoma, Inc. and its subsidiary HairDX, LLC (www.hairdx.com), today unveiled the next generation of its genetic screening test for male pattern baldness. The HairDX test is available immediately thru qualified physicians' offices. Using the HairDX test, a physician can tell a man who tests positive for the high risk genetic variant that he has approximately a 70% chance of going bald. Similarly, a physician can tell a man who...

2008-10-14 00:00:41

Use of a class of medications for treating an enlarged prostate is not associated with an increased hip fracture risk, U.S. researchers said. Benign prostatic hyperplasia, or an enlarged prostate, is a common condition that affects some 8 million U.S. men and treatment includes surgical procedures, minimally invasive procedures and medications. Most often the first-line therapy is pharmacological, using either alpha-blockers, or 5-alpha reductase inhibitors such as finasteride or...

2008-09-19 09:00:11

Nymox Pharmaceutical Corporation (NASDAQ:NYMX) is pleased to announce two separate presentations of new data by independent clinical investigators involved in U.S. clinical trials of NX-1207, Nymox's investigational drug for benign prostatic hyperplasia (BPH). The first presentation was at the annual meeting of the Northeastern Section of the American Urological Association in Santa Ana Pueblo, NM; the second at the annual meeting of the South Central Section of the American Urological...

2008-07-31 21:00:37

PALO ALTO, Calif. _ Watch out, Rogaine. Stanford University researchers have pinpointed a molecule that triggers hair follicle growth in mice, a treatment that one day could eventually mean some shaggy dos, or at least a few more strands, for humans who have experienced hair loss. The report, published Thursday in the Journal of Genes and Development, focuses on a molecule called laminin-511. The molecule acts like an operator, transferring messages, or proteins, between the outer and...


Word of the Day
snash
  • To talk saucily.
  • Insolent, opprobrious language; impertinent abuse.
This word is Scots in origin and probably imitative.